BiotechTube

Hyperphosphatemia

12 competing products in clinical development for Hyperphosphatemia.

Pipeline by Phase

Pre-clinical2
Phase 12
Phase 24
Phase 34

All Products (12)

ProductCompanyStageStatusHype
KHK7791 + PlaceboKyowa KirinPhase 3Completed
40
KHK7791 + PlaceboKyowa KirinPhase 3Completed
40
KHK7791Kyowa KirinPhase 3Completed
40
KHK7791Kyowa KirinPhase 3Completed
40
ASP1585 + Placebo + Sevelamer hydrochlorideAstellas PharmaPhase 2Completed
35
KHK7791 + PlacebpKyowa KirinPhase 2Completed
35
KHK7791Kyowa KirinPhase 2Completed
35
KHK7791 + PlaceboKyowa KirinPhase 2Completed
35
the standard-dose group (4 g/day)Kyowa KirinPre-clinicalRecruiting
33
the low-dose group (1.5 g/day) or the standard-dose group (4 g/day)Kyowa KirinPre-clinicalRecruiting
33
EOS789 + Placebo + RenvelaChugai PharmaceuticalPhase 1Completed
29
DS-2330b PIB + Placebo + Sevelamer + DS-2330b TabletDaiichi SankyoPhase 1Completed
29